Strides Pharma Science's Stock Reaches 52-Week High, Outperforms Sector and Sensex

Strides Pharma Science, a midcap pharmaceutical company, has recently reached a new milestone as its stock price touched a 52-week high on October 17, 2024. The company's stock has been performing well, with a 'Hold' recommendation from MarketsMOJO, a leading stock market analysis platform.

The stock is also a part of Momentumnow Stocks on MarketsMOJO since April 3, 2024. Today, Strides Pharma's stock outperformed the sector by 0.47% and reached an intraday high of Rs 1663.9, a 2.39% increase from the previous day's close. The stock has been on a consecutive gain for the last 3 days and has seen a 5.01% increase in returns during this period.

Strides Pharma is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its stock performance. In the past year, the company's stock has shown an impressive growth of 216.41%, outperforming the Sensex's performance of 22.75%.

As a midcap player in the pharmaceutical industry, Strides Pharma Science has been making strides in its business and stock performance. With its recent 52-week high, the company continues to show promising growth and potential in the market.